Related Experiment Videos
Investigation into the pharmacodynamics of the carcinogen N-nitrodimethylamine
1German Cancer Research Center, Heidelberg.
Abstract:
N-Nitrodimethylamine (NTDMA) was found to be a carcinogen of the nasal mucosa leading to aesthesioneuroepitheliomas in BDVI rats. N-Nitromethylamine (NTMA), a product of the oxidative metabolism of NTDMA, was also carcinogenic, leading to neurogenic tumours of the lumbar region of the spine. The 100,000 X g supernatant of both liver and nasal mucosa contains an enzyme capable of reducing NTDMA to N-nitrosodimethylamine (NDMA). In the microsomal fraction of both organs, NTDMA is oxidized to formaldehyde. The fractions from nasal mucosa have a higher capacity than the corresponding liver fractions to both oxidize and reduce NTDMA. NDMA was detected in blood and urine from rats treated with NTDMA. The elimination of NTDMA from blood occurs biphasically, with an initial half-life of 3.5 min.
Insights
N-Nitrodimethylamine (NTDMA) is a nasal carcinogen in rats, causing tumors. Its metabolite, N-Nitromethylamine (NTMA), also causes spinal tumors, indicating significant carcinogenic potential and metabolic pathways.
Area of Science:
- Toxicology and Carcinogenesis
- Metabolic Biochemistry
- Oncology Research
Background:
- N-Nitrodimethylamine (NTDMA) exposure is linked to nasal cavity cancers.
- Metabolism of NTDMA can produce other carcinogenic compounds.
- Understanding the metabolic fate of NTDMA is crucial for risk assessment.
Purpose of the Study:
- To investigate the carcinogenic effects of N-Nitrodimethylamine (NTDMA) and its metabolite N-Nitromethylamine (NTMA) in rats.
- To identify the metabolic pathways and enzymatic activities involved in NTDMA transformation in liver and nasal mucosa.
- To determine the distribution and elimination kinetics of NTDMA and its metabolites in vivo.
Main Methods:
- Administration of NTDMA to BDVI rats.
- Biochemical analysis of liver and nasal mucosa fractions (supernatant and microsomal) to assess enzymatic activity.
- Detection and quantification of NTDMA and N-nitrosodimethylamine (NDMA) in blood and urine.
- Pharmacokinetic analysis of NTDMA elimination from blood.
Main Results:
- NTDMA induced aesthesioneuroepitheliomas in the nasal mucosa and NTMA caused spinal neurogenic tumors.
- Enzymatic reduction of NTDMA to N-nitrosodimethylamine (NDMA) occurred in liver and nasal mucosa supernatant.
- NTDMA oxidation to formaldehyde was observed in the microsomal fractions of both organs, with higher activity in nasal mucosa.
- NDMA was detected in rat blood and urine following NTDMA treatment.
- NTDMA exhibited biphasic elimination from blood with a short initial half-life of 3.5 minutes.
Conclusions:
- NTDMA is a potent carcinogen targeting the nasal mucosa, and its metabolite NTMA is also carcinogenic.
- Both liver and nasal mucosa possess enzymatic machinery for NTDMA metabolism, with nasal mucosa showing higher activity.
- The findings highlight the complex metabolic activation and toxicological profile of NTDMA, necessitating further investigation into its carcinogenic mechanisms.